Who is sponsoring Rektus-puu?

Rektus-puu is sponsored by Kuopio University Hospital.

What condition does Rektus-puu study?

Rektus-puu studies Surgery, Pain Postoperative.

What drugs are being tested in Rektus-puu?

Interventions: Levobupivacaine continuous infusion, levobupivacaine bolus dosing, single bolus of levobupivacaine, Placebo.

What is the status of Rektus-puu?

Rektus-puu is currently COMPLETED.

Last reviewed 2023-10-25 · How we verify

Efficacy of Rectal Sheath Analgesia After Midline Laparotomy (Rektus-puu)

NCT02869841 Phase 4 COMPLETED

Midline laparotomy is commonly used in emergency and elective cancer surgery and patients need effective and safe pain treatment after this type of surgery. Nowadays modern anticoagulant therapy may prevent use of central regional blocks in pain management. Therefore in the present study the efficacy and safety of rectus sheath analgesia is studied using different administration techniques. The primary aim is the efficacy of the rectus sheath analgesia measured with pain ratings and the amount rescue opioid used. Secondary aims were concentrations of local anesthetic, rescue opioid and satisfaction to analgesia method used.

Details

Lead sponsor	Kuopio University Hospital
Phase	Phase 4
Status	COMPLETED
Enrolment	57
Start date	2012-01
Completion	2022-12-31

Conditions

Surgery
Pain Postoperative

Interventions

Levobupivacaine continuous infusion
levobupivacaine bolus dosing
single bolus of levobupivacaine
Placebo

Primary outcomes

Amount of rescue analgesic used for pain relief — Time 0 h up to 48 h postoperatively
From onset of rectus sheath analgesia

Countries

Finland